LCMS webinars focusing on Dissolution | LabRulez LCMS

This presentation covers the basics of adapting the dissolution environment for low-dose, extended-release dosage forms (e.g., medical devices).

How to implement quick and proactive measures to reduce and even prevent failures from occurring in the dissolution environment.

Biorelevant Dissolution media has long been a topic of drug release testing and has become a stronger focus in the pharmaceutical industry.

How does the Dissolution workflow and equipment fit into the move to a connected lab environment and where do we see challenges but also opportunities?

Does Amino Acid analysis impact different stages of drug discovery or the manufacturing process? Is it important for protein and peptide identification and quantitation?​

We will explore tools and techniques that address the challenges of these types of analysis by examining several examples and case studies.

Join us to get an update on the latest changes and additions to USP chapter <1724>.

Let’s take a trip to the vet and explore our options.

Join us for a discussions on challenges and how they can be overcome.

Let’s take a closer look at all these questions and try to answer them with our group of experts from the DDG panel and industry experts.